Interstitial lung disease in children.

Area of Science:

• Pediatric Pulmonology
• Rare Diseases
• Genetics

Background:

• Childhood interstitial lung diseases (chILD) present diagnostic challenges due to rarity and overlapping symptoms with common respiratory conditions.
• Infantile interstitial lung disease (ILD) often differs significantly from adult and older pediatric forms.
• chILD represents a spectrum of rare, diffuse lung diseases in children.

Purpose of the Study:

• To review updated recommendations for diagnosing and managing chILD.
• To highlight recent scientific advancements in specific chILD subtypes.
• To underscore the distinct nature of infantile ILD.

Main Methods:

• Review of newly published clinical practice guidelines.
• Analysis of recent studies on chILD characteristics and molecular mechanisms.
• Emphasis on diagnostic tools such as chest CT, genetic testing, and lung biopsy.

Main Results:

• Clinical guidelines now strongly recommend chest CT, genetic testing, and lung biopsy for suspected ILD in children.
• Enhanced understanding of neuroendocrine cell hyperplasia of infancy and ILD related to surfactant gene mutations.
• Despite diagnostic progress, definitive treatments for many chILD forms are still lacking.

Conclusions:

• Early identification and prompt diagnostic evaluation are crucial for managing children with suspected ILD.
• chILD requires systematic clinical approaches and further research to improve patient outcomes.
• Continued investigation is necessary to develop effective therapies for these rare pediatric lung conditions.